Lisa is one of the most distinguished voices in intellectual property law, bringing over 30 years of strategic excellence to the biotechnology and pharmaceutical patent landscape.

As a Shareholder at Casimir Jones, she has become a trusted strategist for global pharmaceutical companies, universities, and innovative startups. Her ability to bridge the gap between cutting-edge science and evolving patent law has made her a sought-after authority, not only in legal counsel but also on the global stage as a thought leader and speaker.

Her influence extends internationally through high-profile speaking engagements at some of the most prestigious industry forums. In 2025 alone, she presented at the Japanese Patent Office on legislative proposals to address drug pricing in the U.S., the IPO Annual Meeting on the role of patents in pharmaceutical innovation, and the BIO International Convention on strategies for funding academic spinouts.

Lisa’s presentations consistently attract standing-room-only audiences and spark industry-wide conversations, underscoring her reputation as a leading voice in both intellectual property law and innovation strategy.

In addition to her international speaking career, Lisa shares her thought leadership through media, publications, and education.

She hosts AUTM on the Air, a podcast with over 250 episodes featuring leaders in technology transfer and innovation, and serves as the author of the globally recognized reference book Global Patent Protection and Enforcement of In Vitro Diagnostic Inventions. Her award-winning contributions, combined with her commitment to advancing diversity and inclusion in STEM and law, position her as not only a premier legal strategist but also a transformative speaker whose insights resonate with audiences worldwide.